AlternativeMed
Ancient Wisdom Natural Remedies Modern Wellness
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases
Quick picks: Abetalipoproteinemia Abortion, Habitual Agenesis Acanthamoeba Keratitis Acanthosis Nigricans Achondrogenesis Achondroplasia Acne Vulgaris Acne Keloid Apert Syndrome
🏥 Disease / Health Topic

Ovarian Neoplasm

Open on HERB 2.0 ↗
14
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00001272
A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients
Completed · Phase 1
NCT00001426
A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer
Completed · Phase 2
NCT01015118
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
Completed · Phase 3
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Ovarian Neoplasm
🏥 Names
Disease Name
Ovarian Neoplasm
Alias Names
Ovarian Cancer; Neoplasm, Ovarian; Ovarian Carcinoma; Ovarian Tumor; Ovarian Neoplasms; Neoplasm of The Ovary; Ovarian Neoplasia; Neoplasm of The Ovaries; Ovarian Neoplasm
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Female Urogenital Diseases and Pregnancy Complications; Neoplasms; Endocrine System Diseases
HPO Class
Neoplasm; Abnormality of the genitourinary system
DO Class
disease of anatomical entity; disease of cellular proliferation
🔗 External References
HERB DB
HBDIS012386 ↗
MeSH
D010051 ↗
HPO
HP:0100615 ↗
Disease Ontology
2394; 4001
DisGeNET
C0919267
🔍 Raw view — every non-empty column on this row (29 fields)
name
Ovarian Neoplasm
alias name
Ovarian Cancer; Neoplasm, Ovarian; Ovarian Carcinoma; Ovarian Tumor; Ovarian Neoplasms; Neoplasm of The Ovary; Ovarian Neoplasia; Neoplasm of The Ovaries; Ovarian Neoplasm
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Female Urogenital Diseases and Pregnancy Complications; Neoplasms; Endocrine System Diseases
hpo disease class
Neoplasm; Abnormality of the genitourinary system
do disease class
disease of anatomical entity; disease of cellular proliferation
umls disease type id
T191
mesh disease class id
C04; C19; C13
hpo disease class id
HP:0000119; HP:0002664
do disease class id
DOID:14566; DOID:7
herb disease id
HBDIS012386
disgenet id
C0919267
mesh id
D010051
hpo id
HP:0100615
do id
2394; 4001

⚗️ Related Ingredients

1 · shared evidence
Taxol

📋 Clinical Trials

12 · subject of clinical study
NCT00001272 A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Sti
→ Ovarian Neoplasms
NCT00001426 A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin
→ Ovarian Neoplasm
NCT01015118 LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel an
→ Ovarian Neoplasms|Peritoneal Neoplasms
NCT01608009 [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer
→ Ovarian Neoplasm
NCT01821833 Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Re
→ Breast Cancer|Ovarian Neoplasm|Pain
NCT02470585 Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therap
→ Ovarian Cancer|Ovarian Neoplasm
NCT00191646 An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That
→ Genital Neoplasms, Female|Fallopian Tube Neoplasms
NCT01462890 Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standar
→ Genital Diseases, Female|Ovarian Diseases|Ovarian
NCT01616303 A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemothera
→ Ovarian Neoplasms
NCT02429687 TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors
→ Ovarian Germ Cell Cancer|Ovarian Neoplasms|Ovarian
NCT02429700 TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors
→ Ovarian Sex Cord Stromal Tumor|Ovarian Neoplasms|O
NCT03648489 Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube o
→ Ovarian Cancer|Ovarian Neoplasms|Ovarian Carcinosa
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables